Tapewire

NYSE · USD

ZBH

ZIMMER BIOMET HOLDINGS, INC.

Export transactions ↓
Tapewire entity
3278
SEC CIK
0001136869
Parsed reports
830

Last 12 months

Inside the activity.

0 purchase rows · 6 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202601
Mar 202601
Apr 202600
May 202602
Jun 202600
Jul 202600
Aug 202600
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 18, 2021 Filed Feb 22, 2021 22:04 UTC
Deltort DidierPresident, EMEA
GrantRestricted Stock Units · Derivative 315 $0.00 $0.00
Disclosure

SEC source: 0001062993-21-001856 · form4.xml · derivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315

Underlying: Common Stock · 315 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 315 RSUs.

F3 · derivative.exercise_date: Earned RSUs will vest on February 26, 2021.

F3 · derivative.expiration_date: Earned RSUs will vest on February 26, 2021.

F2 · derivative.underlying_shares: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 315 RSUs.

F2 · balance_after: On February 26, 2019, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2019 - 2021, with an opportunity for interim payouts after 2019 and 2020 depending on actual performance. As determined on February 18, 2021, based on actual performance for 2020, the reporting person earned 315 RSUs.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:54 UTC GrantPhantom Stock Units · Derivative 179.891 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000115 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,074.82

Underlying: Common Stock · 179.891 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 89.946 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 89.946 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 5.237 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:51 UTC GrantPhantom Stock Units · Derivative 179.891 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000114 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,445.174

Underlying: Common Stock · 179.891 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 13.142 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:51 UTC GrantPhantom Stock Units · Derivative 89.946 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000112 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,040.996

Underlying: Common Stock · 89.946 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.529 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:50 UTC GrantPhantom Stock Units · Derivative 212.599 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000111 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,914.212

Underlying: Common Stock · 212.599 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 46.491 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:50 UTC GrantPhantom Stock Units · Derivative 220.775 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000110 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,312.394

Underlying: Common Stock · 220.775 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 38.152 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:49 UTC GrantPhantom Stock Units · Derivative 179.891 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000107 · form4.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,555.713

Underlying: Common Stock · 179.891 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 20.577 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:49 UTC GrantPhantom Stock Units · Derivative 179.891 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000109 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,394.672

Underlying: Common Stock · 179.891 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 14.859 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:49 UTC GrantPhantom Stock Units · Derivative 204.422 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000106 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,585.269

Underlying: Common Stock · 204.422 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 24.204 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 31, 2020 Filed Jan 5, 2021 21:48 UTC GrantPhantom Stock Units · Derivative 204.422 $0.00 Strike: $152.87 $0.00
Disclosure

SEC source: 0001062993-21-000105 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,333.682

Underlying: Common Stock · 204.422 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 21.94 phantom stock units accrued on October 30, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
December 19, 2020 Filed Dec 21, 2020 21:37 UTC
Hanson Bryan CDirector · President and CEO
Exercise / conversionRestricted Stock Units · Derivative 8,625 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006507 · form4.xml · derivative · entry 3

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 8,625 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F3 · derivative.exercise_date: 8,625 of the RSUs vested on each of December 19, 2018, December 19, 2019 and December 19, 2020.

F3 · derivative.expiration_date: 8,625 of the RSUs vested on each of December 19, 2018, December 19, 2019 and December 19, 2020.

Read SEC document
December 19, 2020 Filed Dec 21, 2020 21:37 UTC
Hanson Bryan CDirector · President and CEO
Tax withholdingCommon Stock 3,997 $150.97 $603,427.09
Disclosure

SEC source: 0001062993-20-006507 · form4.xml · nonDerivative · entry 2

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 59,196

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSU").

Read SEC document
December 19, 2020 Filed Dec 21, 2020 21:37 UTC
Hanson Bryan CDirector · President and CEO
Exercise / conversionCommon Stock 8,625 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006507 · form4.xml · nonDerivative · entry 1

Hanson Bryan C · CIK 0001524349 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,193

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Exercise / conversionRestricted Stock Units · Derivative 1,524 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · derivative · entry 9

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,048

Underlying: Common Stock · 1,524 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2020. The remaining RSUs vest annually in equal portions on December 3, 2021 and December 3, 2022.

F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2020. The remaining RSUs vest annually in equal portions on December 3, 2021 and December 3, 2022.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Exercise / conversionRestricted Stock Units · Derivative 925 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · derivative · entry 8

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,850

Underlying: Common Stock · 925 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2020. The remaining RSUs vest annually in equal portions on December 3, 2021 and December 3, 2022.

F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2020. The remaining RSUs vest annually in equal portions on December 3, 2021 and December 3, 2022.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Exercise / conversionRestricted Stock Units · Derivative 1,089 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · derivative · entry 7

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,178

Underlying: Common Stock · 1,089 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F4 · derivative.exercise_date: 25% of the RSUs vested on December 3, 2020. The remaining RSUs vest annually in equal portions on December 3, 2021 and December 3, 2022.

F4 · derivative.expiration_date: 25% of the RSUs vested on December 3, 2020. The remaining RSUs vest annually in equal portions on December 3, 2021 and December 3, 2022.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Tax withholdingCommon Stock 812 $147.07 $119,420.84
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · nonDerivative · entry 6

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,034

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Exercise / conversionCommon Stock 1,524 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · nonDerivative · entry 5

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,846

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Tax withholdingCommon Stock 493 $147.07 $72,505.51
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · nonDerivative · entry 4

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,322

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Exercise / conversionCommon Stock 925 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · nonDerivative · entry 3

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Tax withholdingCommon Stock 580 $147.07 $85,300.60
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · nonDerivative · entry 2

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,890

F2 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
December 03, 2020 Filed Dec 4, 2020 22:31 UTC
Tornos IvanGrp Pres Global Bus & Americas
Exercise / conversionCommon Stock 1,089 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-006081 · form4.xml · nonDerivative · entry 1

Tornos Ivan · CIK 0001757216 · Grp Pres Global Bus & Americas

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,470

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 123 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on July 9, 2020.

Read SEC document
November 18, 2020 Filed Nov 20, 2020 21:27 UTC
Yi SangPresident, Asia Pacific
SaleCommon Stock 1,200 $152.59 $183,108.00
Disclosure

SEC source: 0001062993-20-005831 · form4.xml · nonDerivative · entry 1

Yi Sang · CIK 0001635943 · President, Asia Pacific

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,145

F1 · balance_after: Includes 122 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan on July 9, 2020.

Read SEC document
November 09, 2020 Filed Nov 12, 2020 21:15 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Exercise / conversionEmployee Stock Option (right to buy) · Derivative 30,040 $0.00 Strike: $60.01 $0.00
Disclosure

SEC source: 0001062993-20-005583 · form4.xml · derivative · entry 3

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 30,040 shares

Expires 2021-03-15

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: Vested annually over four years in increments of 25% each year, commencing on March 16, 2012.

Read SEC document
November 09, 2020 Filed Nov 12, 2020 21:15 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
SaleCommon Stock 30,040 $159.70 $4,797,388.00
Disclosure

SEC source: 0001062993-20-005583 · form4.xml · nonDerivative · entry 2

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,814

F1 · shares: Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 13, 2020.

Read SEC document
November 09, 2020 Filed Nov 12, 2020 21:15 UTC
Phipps Chad FSr. VP/Gen Counsel/Secretary
Exercise / conversionCommon Stock 30,040 $60.10 $1,805,404.00
Disclosure

SEC source: 0001062993-20-005583 · form4.xml · nonDerivative · entry 1

Phipps Chad F · CIK 0001346672 · Sr. VP/Gen Counsel/Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,854

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Securities acquired or sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Mr. Phipps on August 13, 2020.

F2 · balance_after: Includes 296 shares acquired under the Zimmer Biomet Holdings, Inc. Employee Stock Purchase Plan and pursuant to dividend reinvestment between April 20, 2020 and October 28, 2020.

Read SEC document
October 01, 2020 Filed Oct 22, 2020 21:26 UTC
Nichol Carrie AnnVP, Controller & CAO
Exercise / conversionRestricted Stock Units · Derivative 164 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-005120 · form4.xml · derivative · entry 3

Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 491

Underlying: Common Stock · 164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Company's common stock.

F3 · derivative.exercise_date: 164 RSUs vested on October 1, 2020. The remaining 491 RSUs vest annually in thirds on each of October 1, 2021, October 1, 2022 and October 1, 2023.

F3 · derivative.expiration_date: 164 RSUs vested on October 1, 2020. The remaining 491 RSUs vest annually in thirds on each of October 1, 2021, October 1, 2022 and October 1, 2023.

Read SEC document
October 01, 2020 Filed Oct 22, 2020 21:26 UTC
Nichol Carrie AnnVP, Controller & CAO
Tax withholdingCommon Stock 52 $137.40 $7,144.80
Disclosure

SEC source: 0001062993-20-005120 · form4.xml · nonDerivative · entry 2

Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 112

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
October 01, 2020 Filed Oct 22, 2020 21:26 UTC
Nichol Carrie AnnVP, Controller & CAO
Exercise / conversionCommon Stock 164 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-005120 · form4.xml · nonDerivative · entry 1

Nichol Carrie Ann · CIK 0001735952 · VP, Controller & CAO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 164

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:38 UTC GrantPhantom Stock Units · Derivative 202.563 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004781 · form4.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,252.141

Underlying: Common Stock · 202.563 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 12.054 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:38 UTC GrantPhantom Stock Units · Derivative 101.282 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004780 · form4.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,947.521

Underlying: Common Stock · 101.282 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 3.059 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:38 UTC GrantPhantom Stock Units · Derivative 202.563 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004779 · form4.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,889.692

Underlying: Common Stock · 202.563 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 101.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 101.282 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 4.34 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:37 UTC GrantPhantom Stock Units · Derivative 239.393 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004778 · form4.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,655.122

Underlying: Common Stock · 239.393 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 44.452 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:37 UTC GrantPhantom Stock Units · Derivative 248.6 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004776 · form4.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,053.467

Underlying: Common Stock · 248.6 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 36.281 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:36 UTC GrantPhantom Stock Units · Derivative 202.563 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004775 · form4.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,199.922

Underlying: Common Stock · 202.563 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 13.729 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:36 UTC GrantPhantom Stock Units · Derivative 230.185 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004773 · form4.xml · derivative · entry 1

BERNARD BETSY J · CIK 0001166854 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,356.643

Underlying: Common Stock · 230.185 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in four annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F4 · balance_after: Includes 22.742 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:36 UTC GrantPhantom Stock Units · Derivative 202.563 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004774 · form4.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,355.245

Underlying: Common Stock · 202.563 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 19.308 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 30, 2020 Filed Oct 2, 2020 20:35 UTC GrantPhantom Stock Units · Derivative 230.185 $0.00 Strike: $135.76 $0.00
Disclosure

SEC source: 0001062993-20-004772 · form4.xml · derivative · entry 1

BEGLEY CHRISTOPHER B · CIK 0001239420 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,107.32

Underlying: Common Stock · 230.185 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F4 · balance_after: Includes 20.533 phantom stock units accrued on July 31, 2020 under the dividend reinvestment provision of the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 20:21 UTC
Deltort DidierPresident, EMEA
Exercise / conversionRestricted Stock Units · Derivative 1,554 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-004388 · form4.xml · derivative · entry 2

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,108

Underlying: Common Stock · 1,554 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Zimmer Biomet Holdings, Inc. common stock.

F2 · derivative.exercise_date: The RSUs vest as follows: 1,554 vested on each of September 4, 2019 and September 4, 2020; and of the remaining 3,108 RSUs, 1,554 are scheduled to vest on each of September 4, 2021 and September 4, 2022.

F2 · derivative.expiration_date: The RSUs vest as follows: 1,554 vested on each of September 4, 2019 and September 4, 2020; and of the remaining 3,108 RSUs, 1,554 are scheduled to vest on each of September 4, 2021 and September 4, 2022.

Read SEC document
September 04, 2020 Filed Sep 8, 2020 20:21 UTC
Deltort DidierPresident, EMEA
Exercise / conversionCommon Stock 1,554 $0.00 $0.00
Disclosure

SEC source: 0001062993-20-004388 · form4.xml · nonDerivative · entry 1

Deltort Didier · CIK 0001749419 · President, EMEA

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,304

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 21:09 UTC
Upadhyay SuketuExec. VP, CFO
Exercise / conversionRestricted Stock Units · Derivative 3,655 $0.00 $0.00
Disclosure

SEC source: 0000911916-20-000165 · edgar.xml · derivative · entry 3

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,965

Underlying: Common Stock · 3,655 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of Company common stock.

F3 · derivative.exercise_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

F3 · derivative.expiration_date: Vests annually over four years in increments of 25% each year, commencing on July 1, 2020.

Read SEC document
July 01, 2020 Filed Jul 2, 2020 21:09 UTC
Upadhyay SuketuExec. VP, CFO
Tax withholdingCommon Stock 1,079 $119.21 $128,627.59
Disclosure

SEC source: 0000911916-20-000165 · edgar.xml · nonDerivative · entry 2

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,576

F1 · shares: Represents shares withheld by Zimmer Biomet Holdings, Inc. (the "Company") to satisfy tax withholding obligations on the vesting of restricted stock units ("RSUs").

Read SEC document
July 01, 2020 Filed Jul 2, 2020 21:09 UTC
Upadhyay SuketuExec. VP, CFO
Exercise / conversionCommon Stock 3,655 $0.00 $0.00
Disclosure

SEC source: 0000911916-20-000165 · edgar.xml · nonDerivative · entry 1

Upadhyay Suketu · CIK 0001533149 · Exec. VP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,655

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:59 UTC GrantPhantom Stock Units · Derivative 232.303 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000164 · edgar.xml · derivative · entry 1

MICHELSON MICHAEL W · CIK 0001182415 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,037.524

Underlying: Common Stock · 232.303 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:57 UTC GrantPhantom Stock Units · Derivative 116.152 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000163 · edgar.xml · derivative · entry 1

Jafry Syed A. · CIK 0001745891 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,843.18

Underlying: Common Stock · 116.152 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:56 UTC GrantPhantom Stock Units · Derivative 232.303 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000162 · edgar.xml · derivative · entry 1

Hilado Maria Teresa · CIK 0001587868 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,682.789

Underlying: Common Stock · 232.303 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. ("Company") Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: 116.152 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: 116.152 of the units are to be settled in shares of Company common stock within sixty days after cessation of the reporting person's service as a Director. The remaining units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:54 UTC GrantPhantom Stock Units · Derivative 274.54 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000161 · edgar.xml · derivative · entry 1

HIGGINS ARTHUR J · CIK 0001142083 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,371.277

Underlying: Common Stock · 274.54 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in ten annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:53 UTC GrantPhantom Stock Units · Derivative 285.099 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000160 · edgar.xml · derivative · entry 1

HAGEMANN ROBERT · CIK 0001222676 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,768.586

Underlying: Common Stock · 285.099 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

F3 · derivative.expiration_date: Units are to be settled in cash in five annual installments commencing within sixty days after the end of the calendar year in which the cessation of the reporting person's service as a Director occurs.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:52 UTC GrantPhantom Stock Units · Derivative 232.303 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000159 · edgar.xml · derivative · entry 1

Farrell Michael J. · CIK 0001485164 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,983.63

Underlying: Common Stock · 232.303 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:50 UTC GrantPhantom Stock Units · Derivative 232.303 $0.00 Strike: $118.38 $0.00
Disclosure

SEC source: 0000911916-20-000158 · edgar.xml · derivative · entry 1

BOUDREAUX GAIL · CIK 0001287920 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,133.374

Underlying: Common Stock · 232.303 shares

Expires not disclosed

F1 · security: The phantom stock units were accrued under the Zimmer Biomet Holdings, Inc. Deferred Compensation Plan for Non-Employee Directors.

F2 · derivative.exercise_price: The Conversion or Exercise Price of Derivative Security is 1-for-1.

F3 · derivative.exercise_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

F3 · derivative.expiration_date: Units are to be settled in cash in a lump sum within sixty days after cessation of the reporting person's service as a Director.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.